Navigation Links
Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon
Date:10/30/2010

Phase III trials. BI 207127 is an NS5B RNA-dependent polymerase inhibitor that has completed Phase I clinical trials. Planning is currently underway to begin Phase II trials of BI 207127 with BI 201335 in interferon-sparing regimens both with and without ribavirin.

Boehringer Ingelheim Pharmaceuticals, Inc.Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 41,500 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2009, Boehringer Ingelheim posted net sales of US $17.7 billion (12.7 billion euro) while spending 21% of net sales in its largest business segment, Prescription Medicines, on research and development.

For more information, please visit http://us.boehringer-ingelheim.com

www.twitter.com/boehringerUS


'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
5. Tapestry Reports Second Quarter 2007 Results
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... April 20, 2015   Gateway Rehab ... Training Institute today expanded its Naloxone: Increasing Access, ... A $50,000 grant from the Staunton Farm ... possible.  The yearlong research project, ... and their family members upon completion of treatment ...
(Date:4/20/2015)... April 20, 2015 International Isotopes Inc. ... provide shareholders with the following update on its ... Historically, INIS has produced and ... several models of sealed sources for medical and ... radiation therapy, security examination, and radiography.  Due to ...
(Date:4/20/2015)...  Halozyme Therapeutics, Inc. (NASDAQ: HALO ), ... therapies, today shared highlights of new data it ... (AACR) annual meeting. Halozyme also announced plans to ... study in pancreatic cancer, Study 202, next month ... of Clinical Oncology (ASCO). In an ...
Breaking Medicine Technology:Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations 2Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations 3International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 2International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 3International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 4International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 5Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 2Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 3Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 4Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 5
... Watson Pharmaceuticals, Inc. (NYSE: WPI ) today ... a settlement with Endo Pharmaceuticals, Inc. on outstanding patent ...  Endo filed its lawsuit on March 4, 2010, following ... with the U.S. Food and Drug Administration (FDA) for ...
... Oct. 7 Akorn, Inc. (Nasdaq: AKRX ) ... discuss third quarter 2010 results followed by a Q&A session. ... market opens.Subject: , Akorn Third Quarter 2010 Conference CallDate/Time: ... TimeDomestic Callers: , (888) 215-6895International Callers: , (913) ...
Cached Medicine Technology:Watson Reaches Settlement with Endo Over Opana® ER 2
(Date:4/20/2015)... A recent cross-sectional survey involving fibromyalgia ... top 10 most beneficial therapies for fibromyalgia, no drugs were ... therapies, only approved drugs were named. , “The biggest ... effect is only felt as long as the patient is ... , “On the other hand, aerobic exercise and other non-drug ...
(Date:4/20/2015)... Utah (PRWEB) April 20, 2015 Goodreads ... Employer-Provided Health Insurance: Why It’s Good for You and ... , Paul Zane Pilzer and Rick Lindquist have ... Health Insurance: Why It’s Good for You and Your ... nation’s employer health insurance woes - employer-funded individual health ...
(Date:4/20/2015)... York, New York (PRWEB) April 20, 2015 ... trade association representing the U.S. health insurance industry, ... a result of the recent controversy involving surgical ... a letter to U.S. Senator Robert Casey (D-PA) ... safety concerns surrounding uterine morcellation point to “serious ...
(Date:4/20/2015)... 2015 “ Verus ” was featured ... which features the latest and coolest technology products available ... reporter for NewsWatch, conducted the review and shared with ... of purposes. , According to CNET, at least a ... 2013. It’s unfortunate that smartphones break so easily, but ...
(Date:4/20/2015)... (PRWEB) April 20, 2015 Northern ... Medicare & Medicaid Services introduced their new 5-star “Patient ... Consumer Assessment of Healthcare Providers and Systems) survey of ... patients about their experiences during a recent hospital stay. ... July 1, 2013 through June 30, 2014 can be ...
Breaking Medicine News(10 mins):Health News:Medical Doctor in Huntsville Reveals That Aerobic Exercise Offers Best Results in Fibromyalgia Treatment 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 4Health News:Attractive and Durable Phone Cases were Featured on NewsWatch Television 2Health News:Northern Westchester Hospital Named a 5-Star Hospital In Medicare's Patient Satisfaction Rating 2Health News:Northern Westchester Hospital Named a 5-Star Hospital In Medicare's Patient Satisfaction Rating 3
... research is needed to determine the true effects of ... and the impact on pregnant women of different ... say. ,Recommendations for safe levels of ... states and organisations in Australia, according to new report ...
... of yoghurt could contain the cure for certain types ... . ,Overuse of antibiotics has led ... vancomycin-resistant enterococci (VRE), which are responsible for persistent and ... commercial yoghurts, may have a beneficial effect on human ...
... deceased older donors on a pump as opposed to ... cooler may lower hospital costs, improve initial organ ... according to new research by Wake Forest University Baptist Medical ... preservation times can be safely extended to permit more time ...
... this time on what kind of dress is best in a ... denim and wool, Swiss researchers say after reviewing 500 studies from ... ,Writing in a study published online by the Lancet, they ... ,The team from the Triemli Hospital, Zurich, Switzerland, said wearing clothes ...
... long ago there was a theory doing the rounds that ... autistic individual. This theory was not well received and ... prompted the proponents of the theory to associate the schemingly ... autism? ,Autism is a developmental disability that affects ...
... The U.S. Food and Drug Administration (FDA) today issued ... all of its medical devices remaining in the ... ,On April 17, 2007, U.S. Marshals, at FDA's ... Union, N.J. facility after finding significant deficiencies in the ...
Cached Medicine News:Health News:Better Research Needed On Alcohol In Pregnancy 2Health News:Preserving Kidneys on a Pump May Promote More Organ Sharing 2Health News:Denim, Not Cotton, Apt Wear for Summer 2Health News:Diet for Autism 2Health News:Diet for Autism 3
... Superior Alternative to Bottled Water, The ... alternative for laboratories that currently use bottled ... to purchase, ship and store bottled water, ... - as contamination can be absorbed from ...
... Produces up to 12 L/min of Type ... On Demand, The Super-Q Plus System is ... water which has been pretreated by reverse ... consistently produce ultrapure water quality which exceeds ...
... Laboratory Needs, Synergy systems produce ultrapure water from ... to 1.2 L/min to meet the basic needs ... a dual-wavelength UV lamp (185 nm and 254 ... organic contaminants (< 5 ppb TOC when fed ...
... mechanism for speed, stability and durability. ... display modes, multiple units of measure, ... auto print, and GLP/GMP/ISO output including ... clock. Built-in, motor-driven internal calibration ...
Medicine Products: